Pharma Industry News

Crohn’s Disease Phage Therapy Neutralizes Inflammatory E. coli in Mouse Model

Researchers developed a supportive bacteriophage therapy for Crohn’s disease that in a mouse model neutralized a type of E. coli bacteria that drives inflammation in the gut, and improved responses to low doses of a conventional corticosteroid. The post Crohn’s Disease Phage Therapy Neutralizes Inflammatory E. coli in Mouse Model appeared first on GEN – Genetic Engineering and Biotechnology News.

Source: Genetic Engineering & Biotechnology News

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]